₹1,750.00 1.05 (0.06%)
04:01 PM, 2-Jan-2026₹1,749.30-1.50 (-0.09%)
03:53 PM, 2-Jan-2026BSE : 543349
NSE : ACUTAAS
Sector : Health care
ISIN Code : INE00FF01025
Last Updated: 02-Jan-2026 | 04:01 PM IST
| Market Cap (₹ Cr) | 14,329 |
Traded Value (₹ Cr) | 1.04 |
Volume (Shares) | 5,916 |
Face Value (₹) | 5 |
52-Week High (₹) | 1,901.35 |
52-Week High Date | 24-Nov-2025 |
52-Week Low (₹) | 919.63 |
52-Week Low Date | 28-Jan-2025 |
All Time High (₹) | 1,901.35 |
All Time High Date | 24-Nov-2025 |
All Time Low (₹) | 382.08 |
All Time Low Date | 24-Feb-2022 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 14,323 |
| EPS - TTM (₹) [C] | 27.36 |
| P/E Ratio (X) [C] | 63.94 |
| Face Value (₹) | 5 |
| Latest Dividend (%) | 30.00 |
| Latest Dividend Date | 18-Sep-2025 |
| Dividend Yield (%) | 0.09 |
| Book Value Share (₹) [C] | 172.67 |
| P/B Ratio (₹) [C] | 10.13 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| SBI Large & Midcap Fund (IDCW) | 367.50 | 20,00,000 | 0.99 |
| SBI Large & Midcap Fund (G) | 367.50 | 20,00,000 | 0.99 |
| SBI Large & Midcap Fund - Direct (G) | 367.50 | 20,00,000 | 0.99 |
| SBI Large & Midcap Fund - Direct (IDCW) | 367.50 | 20,00,000 | 0.99 |
| Kotak Multicap Fund (G) | 251.03 | 13,66,139 | 1.13 |
| Kotak Multicap Fund - Direct (G) | 251.03 | 13,66,139 | 1.13 |
| Kotak Multicap Fund (IDCW) RI | 251.03 | 13,66,139 | 1.13 |
| Kotak Multicap Fund - Direct (IDCW) RI | 251.03 | 13,66,139 | 1.13 |
| SBI Healthcare Opportunities Fund (IDCW) | 165.38 | 9,00,000 | 4.00 |
| SBI Healthcare Opportunities Fund (G) | 165.38 | 9,00,000 | 4.00 |
Load more
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| 13-Mar-2025 | JM Financial | Buy | 2,605 | |
| 11-Mar-2025 | InCred Equities | Reduce | 1,500 |
| Today's Low/High (₹) | 1,732.50 1,765.00 |
| Week Low/High (₹) | 1,625.00 1,770.00 |
| Month Low/High (₹) | 1,613.20 1,779.00 |
| Year Low/High (₹) | 918.78 1,902.00 |
| All time Low/High (₹) | 382.08 1,902.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 5.91% | 5.83% | 0.85% | 1.10% |
| 1 Month | 0.28% | 0.34% | 0.73% | 1.14% |
| 3 Month | 26.56% | 26.62% | 5.90% | 6.01% |
| 6 Month | 59.28% | 59.64% | 2.82% | 3.44% |
| 1 Year | 66.57% | 66.63% | 7.28% | 8.85% |
| 3 Year | 262.83% | 262.74% | 40.21% | 44.68% |
Executive Chairman & M.D. : Nareshbhai Ramjibhai Patel
E D & Wholetime Director : Chetankumar Chhaganlal Vaghasia
E D & Wholetime Director : Virendra Nath Mishra
E D & Wholetime Director : Ram Mohan Rao Locande
Independent Non Exe. Director : Girikrishna Maniar
Independent Non Exe. Director : Hetal Gandhi
Independent Non Exe. Director : Richa M. Goyal
Independent Non Exe. Director : Anita Bandyopadhyay
CS / Compliance Officer / Legal Head : Ekta Kumari Srivastava
Registered Office: Plot No 440/4 5&6, Road No 82/A GIDC Sachin,Surat,Gujarat-394230 Ph: 91-261-2397193/91-7227977744
Email:cs@amiorganics.com
1. What's the Acutaas Chemicals Ltd share price today?
Acutaas Chemicals Ltd share price was Rs 1,750.00 at 04:01 PM IST on 2nd Jan 2026. Acutaas Chemicals Ltd share price was up by 0.06% over the previous closing price of Rs 1,748.95. Acutaas Chemicals Ltd share price trend:
2. How can I quickly analyse the performance of the Acutaas Chemicals Ltd stock?
The performance of the Acutaas Chemicals Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd has a market capitalisation of Rs 14,329 crore.
4. What is Acutaas Chemicals Ltd's 52-week high/low share price?
The Acutaas Chemicals Ltd’s 52-week high share price is Rs 1,901.35 and 52-week low share price is Rs 919.63.
5. Is the Acutaas Chemicals Ltd profitable?
On a consolidated basis, Acutaas Chemicals Ltd reported a profit of Rs 71.86 crore on a total income of Rs 316.03 crore for the quarter ended 2025.
6. Which are Acutaas Chemicals Ltd’s peers in the Health care sector?
Acutaas Chemicals Ltd’s top 5 peers in the Health care sector are Alembic Pharma, Natco Pharma, Granules India, Acutaas Chemical, Caplin Point Lab, Concord Biotech, Alivus Life.
7. Who owns how much in Acutaas Chemicals Ltd?
Key changes to the Acutaas Chemicals Ltd shareholding are as follows: